drugset / Trial / NCT03698695

A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers

NCT03698695

Phase 1 Completed 152 enrolled Theranexus
RandomizedParallel-groupTriple-blindTreatment

Summary

This study explores the safety, pharmacodynamics and pharmacokinetics of THN201 a combination of donepezil and mefloquine to improve cognitive function in healthy male volunteers after impairment by a scopolamine challenge.

Timeline

Start
2018-09-27
Primary completion
2019-10-20
Completion
2019-12-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Donepezil Small molecule 5 mg Oral
Subject Mefloquine Unknown 10 mg Oral